IFNA1 and viral infectious disease: However, the SP600125 treatment reversed this phenomenon of IFN-β at the late time point of CHv infection, indicating that inhibiting the activation of the JNK pathway will be beneficial to the regulation of the IFN signaling pathway under virus infection.